TELA Bio, Inc. (TELA) Q1 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Tela Bio, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:05.159 Good afternoon, ladies and gentlemen, and welcome to the Telebio First Quarter 2025 earnings 00:00:05.159 -- 00:00:09.245 conference call. At this time, all participants are in listen-only mode. 00:00:09.245 -- 00:00:12.590 Following the prepared remarks, there will be a question and answer session. 00:00:12.590 -- 00:00:15.895 Please be advised that today's conference is being recorded. 00:00:15.895 -- 00:00:21.881 I would now like to turn the conference over to Louisa Smith from Gilmartin Group. 00:00:22.846 -- 00:00:25.428 Thank you, Gerald, and good afternoon, everyone. 00:00:25.428 -- 00:00:31.415 Earlier today, Telebio released financial results for the first quarter, 2025. 00:00:31.415 -- 00:00:35.739 A copy of the press release is available on the company's website. 00:00:35.739 -- 00:00:41.265 Joining me on today's call are Tony Koblish, President and Chief Executive Officer, and 00:00:41.265 -- 00:00:46.451 Roberto Cuca, Chief Operating Officer and Chief Financial Officer. 00:00:46.451 -- 00:00:50.696 Before we begin, I'd like to remind you that during this conference call, the company 00:00:50.696 -- 00:00:55.060 may make projections and forward-looking statements regarding future events. 00:00:55.060 -- 00:01:00.226 We encourage you to review the company's past and future filings with the SEC, 00:01:00.226 -- 00:01:05.632 including, without limitation, the company's annual report on Form 10-K 00:01:05.632 -- 00:01:10.959 and quarterly reports on Forms 10-Q, which identify the specific factors 00:01:10.959 -- 00:01:16.185 that may cause actual results or events to differ materially from those described 00:01:16.185 -- 00:01:18.608 in these forward-looking statements. 00:01:18.608 -- 00:01:24.005 These factors may include...